全文获取类型
收费全文 | 36795篇 |
免费 | 3834篇 |
国内免费 | 1241篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 1313篇 |
妇产科学 | 200篇 |
基础医学 | 3158篇 |
口腔科学 | 155篇 |
临床医学 | 3340篇 |
内科学 | 4888篇 |
皮肤病学 | 271篇 |
神经病学 | 535篇 |
特种医学 | 864篇 |
外国民族医学 | 1篇 |
外科学 | 14343篇 |
综合类 | 5299篇 |
现状与发展 | 2篇 |
一般理论 | 1篇 |
预防医学 | 1139篇 |
眼科学 | 201篇 |
药学 | 2558篇 |
18篇 | |
中国医学 | 2786篇 |
肿瘤学 | 723篇 |
出版年
2024年 | 131篇 |
2023年 | 855篇 |
2022年 | 1374篇 |
2021年 | 2313篇 |
2020年 | 1676篇 |
2019年 | 1891篇 |
2018年 | 1739篇 |
2017年 | 1650篇 |
2016年 | 1663篇 |
2015年 | 1719篇 |
2014年 | 2518篇 |
2013年 | 2607篇 |
2012年 | 1867篇 |
2011年 | 2172篇 |
2010年 | 1872篇 |
2009年 | 1655篇 |
2008年 | 1679篇 |
2007年 | 1598篇 |
2006年 | 1501篇 |
2005年 | 1326篇 |
2004年 | 1130篇 |
2003年 | 988篇 |
2002年 | 824篇 |
2001年 | 768篇 |
2000年 | 556篇 |
1999年 | 469篇 |
1998年 | 372篇 |
1997年 | 306篇 |
1996年 | 310篇 |
1995年 | 297篇 |
1994年 | 260篇 |
1993年 | 193篇 |
1992年 | 200篇 |
1991年 | 185篇 |
1990年 | 131篇 |
1989年 | 144篇 |
1988年 | 116篇 |
1987年 | 105篇 |
1986年 | 83篇 |
1985年 | 90篇 |
1984年 | 83篇 |
1983年 | 51篇 |
1982年 | 58篇 |
1981年 | 59篇 |
1980年 | 49篇 |
1979年 | 53篇 |
1978年 | 40篇 |
1977年 | 38篇 |
1976年 | 29篇 |
1975年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
Gerald S. Lipshutz Harish Mahanty Sandy Feng Ryutaro Hirose Peter G. Stock Sang-Mo Kang rew M. Posselt Chris E. Freise 《American journal of transplantation》2005,5(2):366-373
With the introduction of more potent immunosuppressive agents, rejection has decreased in simultaneous pancreas/kidney transplant (SPK) recipients. However, as a consequence, opportunistic infections have increased. The purpose of this report is to outline the course of SPK patients who developed polyomavirus-associated nephropathy (PVAN). A retrospective review of 146 consecutive SPK recipients from January 1, 1996 to December 31, 2002 was performed. Immunosuppression, rejection and development of PVAN were reviewed. Nine patients were identified. All received induction with either OKT3 or thymoglobulin. Immunosuppression included tacrolimus/cyclosporine, MMF/azathioprine and sirolimus/prednisone. Two patients were treated for kidney rejection prior to the diagnosis of PVAN. Time to diagnosis was an average of 359.3 days post-transplantation. Immunosuppression was decreased but five ultimately lost function. However, none developed pancreatic abnormalities as demonstrated by normal glucose and amylase. Two underwent renal retransplantation after PVAN diagnosis and both have normal kidney function. PVAN was the leading cause of renal loss in SPK patients in the first 2 years after transplantation and is a serious concern for SPK recipients. The pancreas, however, is spared from evidence of infection, and no pancreatic rejection occurred when immunosuppression was decreased. 相似文献
122.
123.
目的通过观察菲立磁标记兔骨髓源性神经干细胞(BMSCs)自体移植脊髓后的核磁共振活体示踪及形态,期待找到一种应用非侵袭性方法来识别、跟踪BMSCs的存活状态及与宿主组织整合情况的方法。方法无菌条件下股骨取骨髓,梯度密度离心法分离获取兔骨髓基质细胞;使用“Feridex-多聚赖氨酸复合物(FE-PLL)”标记骨髓基质细胞,采用普鲁士兰染色和台盼蓝排除实验等方法鉴定FE-PLL标记兔骨髓基质细胞的效率和细胞的活力;体外标记的细胞自体脊髓移植,磁共振、免疫组织化学染色和透射电镜检查。结果普鲁士蓝染色显示FE-PLL标记骨髓基质细胞胞质内出现细小的蓝色铁颗粒;与正常未标记的细胞相比较,FE-PLL标记对骨髓基质细胞的活力、增殖和分化等能力没有明显的影响;经菲立磁标记的兔BMSCs自体脊髓移植后,可在核磁共振上活体示踪。结论菲立磁与核磁共振联合可无创性活体标记检测移植的神经干细胞基本的存在部位、存在方式及其一些生物学特性,可以用来活体示踪移植的BMSCs。 相似文献
124.
AIMS: Laparoscopic nephrectomy has become a standardized procedure for removal of benign non-functioning kidneys. We present our experience of retroperitoneoscopic pre-transplant native kidneys nephrectomy. METHODS: Comparison of 40 patients who underwent retroperitoneoscopy with 40 open simple pre-transplant nephrectomy patients was done. RESULTS: Forty retroperitoneoscopic nephrectomies were done between June 2003 and April 2005. The mean operative time was similar in the two groups; however, the mean blood loss, postoperative analgesic requirement, complication rate, hospital stay and convalescence period were significantly less in the retroperitoneoscopic group. CONCLUSION: Retroperitoneoscopic nephrectomy should be offered as the primary treatment modality to patients requiring pre-transplant native kidney nephrectomy, except in patients where it is contraindicated. 相似文献
125.
K. Wyburn H. Wu G. Chen J. Yin J. Eris S. Chadban 《American journal of transplantation》2006,6(11):2612-2621
Interleukin-18 is predominantly a macrophage-derived cytokine with a key role in inflammation and cell-mediated immunity. Having previously demonstrated IL-18 upregulation in a rat model of kidney rejection, here we examined IL-18 in a fully MHC-mismatched murine model of acute kidney rejection using IL-18-deficient recipients (IL-18-/-) and animals administered neutralizing IL-18 binding protein (IL-18BP). Gene expression of IL-18 and its receptor were significantly upregulated in allografts compared to isografts, as was the cellular infiltrate (T cells and macrophages) (p < 0.001). Allografts developed kidney dysfunction (p < 0.05) and tubulitis (p < 0.01) not observed in controls. There was a significant reduction in gene expression of IL-18 downstream pro-inflammatory molecules (iNOS, TNFalpha and IFNgamma) in IL-18-/- recipients (p < 0.01), and IL-18BP-treated animals. The CD4+ infiltrate and IL-4 mRNA expression was greater in the IL-18-/- recipients than wild-type (WT) allografts and IL-18BP-treated animals (p < 0.05), suggesting a Th2-bias which was supported by IFNgamma and IL-4 ELISPOT data and an increased eosinophil accumulation (p < 0.001). Neither IL-18 deficiency nor neutralization prevented renal dysfunction or tubulitis. This study demonstrates increased production of IL-18 in murine kidney allograft rejection and provides evidence that IL-18-induced pathways of inflammation are active. However, neither IL-18 deficiency nor neutralization was protective against the development of allograft rejection. 相似文献
126.
M. Myslak H. Amer P. Morales M. E. Fidler J. M. Gloor T. S. Larson M. D. Stegall F. G. Cosio 《American journal of transplantation》2006,6(7):1660-1665
Increasing numbers of patients receive kidney transplants before initiation of dialysis or shortly thereafter. Some of these patients have significant proteinuria pre-transplant making the interpretation of post-transplant proteinuria problematic. In this study, we evaluated post-transplant proteinuria in 115 patients who had urine protein measured within 3 months of transplant and assessed the association of proteinuria with allograft pathology. Proteinuria declined rapidly from 3650 +/- 3702 mg/day pre-transplant to 550 + 918 at 3 weeks (p < 0.0001) and continued to decline until 1 year post-transplant (472 +/- 1116, p < 0.0001 vs. 3 weeks). Proteinuria greater than 3000 mg/day was present in 48 patients (42%) pre-transplant, in 1 patient (1%) at 3 weeks and in 4 patients (4%) at 1 year. Surveillance graft biopsies were done at 1 year in 93% of patients. Proteinuria > or = 1500 mg/day and/or an absolute increase in proteinuria > 500 mg/day after 3 weeks post-transplant was associated with allograft glomerular pathology. In conclusion, pre-transplant proteinuria, even when high grade, declines rapidly after transplantation. Failure to decline or persistence of proteinuria greater than 1500 mg/day is indicative of allograft pathology. 相似文献
127.
J.T. Carter M.L. Melcher L.L. Carlson M.E. Roland P.G. Stock 《American journal of transplantation》2006,6(4):753-760
HIV-infected patients are increasingly referred for kidney transplantation, and may be at an increased risk for rejection. Treatment for rejection frequently includes thymoglobulin. We studied thymoglobulin's effect on CD4+ T-cell count, risk of infection and rejection reversal in 20 consecutive HIV-infected kidney recipients. All patients used antiretroviral therapy and opportunistic infection prophylaxis. Maintenance immunosuppression consisted of prednisone, mycophenolate mofetil and cyclosporine. Eleven patients received thymoglobulin (7 for rejection and 4 for delayed/slow graft function) while 9 did not. These two groups were similar in age, gender, race, donor characteristics and immunosuppression. Mean CD4+ T-cell counts remained stable in patients who did not receive thymoglobulin, but became profoundly suppressed in those who did, decreasing from 475 +/- 192 to 9 +/- 10 cells/microL (p < 0.001). Recovery time ranged from 3 weeks to 2 years despite effective HIV suppression. Although opportunistic infections were successfully suppressed, low CD4+ T-cell count was associated with increased risk of serious infections requiring hospitalization. Rejection reversed in 6 of 7 patients receiving thymoglobulin. We conclude that thymoglobulin reverses acute rejection in HIV-infected kidney recipients, but produces profound and long-lasting suppression of the CD4+ T-cell count associated with increased risk of infections requiring hospitalization. 相似文献
128.
SB203580对肾缺血/再灌注损伤时细胞凋亡及p38MAPK影响的实验研究 总被引:9,自引:0,他引:9
目的 探讨不同时间及不同浓度p38MAPK特异性抑制剂SB2 0 35 80对肾缺血 /再灌注损伤过程中肾功能、细胞凋亡及 p38MAPK活性、表达量、p38MAPK底物的影响。 方法 4 9只大鼠按缺血 /再灌注及给药时间的不同 ,随机分为 7组 ,每组7只大鼠按正交拉丁方表的顺序 ,经尾静脉注射相同体积、不同剂量的SB ,使其在大鼠体内达到不同的浓度。测定BUN和Scr;用TUNEL试剂盒检测细胞凋亡情况 ;Westernblot技术用于蛋白定性及半定量分析。结果 SB可显著减轻大鼠肾缺血 /再灌注损伤造成的Scr和BUN的升高、肾小管上皮细胞的凋亡及 p38MAPK的激活 ,但存在模型、剂量及给药时机的差异 (P<0 .0 5 ) ,缺血前 3h之前给药 ,使其体内血药浓度达到 5 μmol/L左右可取得较好的效果。 结论 SB可显著减轻大鼠肾缺血 /再灌注损伤 ,在缺血前 3h之前给药 ,同时使其血药浓度达到 5 μmol/L左右可取得最佳效果。 相似文献
129.
CHEN JUN XU ZHISHUN JIANG XIANZHOU FU QIANG WANG JIN 《International journal of urology》2006,13(5):515-519
AIM: To study the association between age and clinical characteristics of renal cell carcinoma in adult patients. METHODS: Three hundred and ten patients with renal cell carcinoma were classified into three groups: or=60 years group. The clinical characteristics of the three groups were compared to define the association. RESULTS: The male/female ratio was 1.3/1, 2.0/1, 3.3/1 in the three groups, respectively, and a significant difference appeared when comparing the or=60 years group (P=0.010). The respective percentage of incidental renal cell carcinoma was 27.9%, 43.2%, 31.2%, and it was significantly higher in the 41-59 years group than the >or=60 years group (P=0.047). The incidence of poorly differentiated renal cell carcinoma decreased with age increasing (11.6% vs 5.2% vs 2.7%), and there was significant difference between the or=60 years group (P=0.038). In the 相似文献
130.
带血管骨膜瓣移植修复烧伤坏死管状骨的实验研究 总被引:3,自引:1,他引:2
目的探讨带血管骨膜瓣移植修复烧伤坏死管状骨的可行性,试图为临床修复烧伤坏死骨提供一种有效的方法。方法8月龄成年新西兰家兔20只,设一侧肢体的桡骨为实验组,另一侧为对照组,采用同体对照法。实验组保留带血管的骨膜瓣,从桡骨中下段离断1.2cm桡骨,置沸水中煮沸30min冷却后原位回植,再行骨膜瓣移植包绕、固定。对照组按上述方法处理后不移植骨膜瓣。分别于术后2、4、6、8~10、12周摄X线平片,同时分别处死4~5只兔并取两侧桡骨行组织学切片检查。结果实验组:术后2~4周在骨坏死区见到明显的骨膜增生影像;术后6~8周见骨折断端连接征象,新生骨小梁形成并逐渐改建;术后8—10周可见网织骨普遍融合重建,形成板层,新的哈佛系统形成;术后12周新生骨结构更加成熟,骨折愈合。对照组:术后2周仍为死骨,骨坏死区无骨膜增生现象;术后4、6周未见骨折愈合征象;8周可见骨缺损;12周坏死骨完全溶解、吸收,骨缺损区清晰可见,骨缺损区被少许纤维组织充填。结论带血供的骨膜瓣能不断形成新生骨并爬行替代原坏死骨,使坏死骨获得再生,能很好地修复烧伤坏死的管状骨。 相似文献